BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12064004)

  • 1. Successful treatment of a T1 cancer of the pancreatic head with high dose rate brachytherapy and external radiotherapy.
    Takácsi-Nagy Z; Varga J; Poller I; Fodor J; Polgár C; Petrányi A; Major T; Németh G
    Hepatogastroenterology; 2002; 49(45):844-6. PubMed ID: 12064004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful treatment of a localised pancreatic cancer with radiotherapy alone: a case report].
    Takácsi ZN; Varga J; Poller I; Fodor J; Major T; Németh G
    Magy Onkol; 2003; 47(2):161-3. PubMed ID: 12975663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3D-Ct-planned interstitial HDR brachytherapy + percutaneous irradiation and chemotherapy in inoperable pancreatic carcinoma. Methods and clinical outcome].
    Pfreundner L; Baier K; Schwab F; Willner J; Bratengeier K; Flentje M; Feustel H; Fuchs KH
    Strahlenther Onkol; 1998 Mar; 174(3):133-41. PubMed ID: 9524622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined isodose curves of high-dose rate interstitial brachytherapy with external-beam radiation therapy in pancreatic carcinoma.
    Warszawski N; Pfreundner L; Bratengeier K; Bohndorf W; Feustel H
    Strahlenther Onkol; 1992 Sep; 168(9):552-7. PubMed ID: 1384154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis.
    Weitmann HD; Pötter R; Waldhäusl C; Nechvile E; Kirisits C; Knocke TH
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):468-78. PubMed ID: 15890589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of recurrent pancreatic carcinoma treated by low-dose rate telecobalt therapy].
    Yamada S; Ishibashi T; Sasauchi S; Takai Y; Koyama K; Hoshino F
    Gan No Rinsho; 1984 Jan; 30(1):75-80. PubMed ID: 6700117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose-rate intracavitary brachytherapy combined with external beam radiotherapy for stage IIIb adenocarcinoma of the uterine cervix in Japan: a multi-institutional study of Japanese Society of Therapeutic Radiology and Oncology 2006-2007 (study of JASTRO 2006-2007).
    Niibe Y; Kenjo M; Onishi H; Ogawa Y; Kazumoto T; Ogino I; Tsujino K; Harima Y; Takahashi T; Anbai A; Tsuchida E; Toita T; Takemoto M; Yamashita H; Hayakawa K
    Jpn J Clin Oncol; 2010 Aug; 40(8):795-9. PubMed ID: 20444747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
    Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
    Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 125I interstitial implant, precision high-dose external beam therapy, and 5-FU for unresectable adenocarcinoma of pancreas and extrahepatic biliary tree.
    Dobelbower RR; Merrick HW; Ahuja RK; Skeel RT
    Cancer; 1986 Nov; 58(10):2185-95. PubMed ID: 3756765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
    Momma T; Saito S; Toya K; Yorozu A; Dokiya T; Murai M
    Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic ultrasound-guided interstitial brachytherapy of unresectable pancreatic cancer: results of a pilot trial.
    Sun S; Xu H; Xin J; Liu J; Guo Q; Li S
    Endoscopy; 2006 Apr; 38(4):399-403. PubMed ID: 16680642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perineal template interstitial brachytherapy salvage for recurrent endometrial adenocarcinoma metastatic to the vagina.
    Nag S; Martínez-Monge R; Copeland LJ; Vacarello L; Lewandowski GS
    Gynecol Oncol; 1997 Jul; 66(1):16-9. PubMed ID: 9234914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palladium-103: a new radioactive source in the treatment of unresectable carcinoma of the pancreas: a phase I-II study.
    Nori D; Merimsky O; Osian AD; Heffernan M; Cortes E; Turner JW
    J Surg Oncol; 1996 Apr; 61(4):300-5. PubMed ID: 8628003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose rate brachytherapy of prostatic adenocarcinoma in combination with external beam radiotherapy a long-term follow-up of the first 50 patients at one center.
    Lennernäs B; Holmäng S; Hedelin H
    Strahlenther Onkol; 2002 Oct; 178(10):537-41. PubMed ID: 12386784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the duct of Wirsung.
    Mutignani M; Shah SK; Morganti AG; Perri V; Macchia G; Costamagna G
    Endoscopy; 2002 Jul; 34(7):555-9. PubMed ID: 12170409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma.
    Pasquier D; Mirabel X; Adenis A; Rezvoy N; Hecquet G; Fournier C; Coche-Dequeant B; Prevost B; Castelain B; Lartigau E
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1456-61. PubMed ID: 16863928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.